BROOKFIELD, NEWS, Jan. 13, 2025 (GLOBE NEWSWIRE) — Brookfield Corporation (NYSE: BN, TSX: BN) will host its fourth quarter 2024 conference call and webcast on Thursday, February 13, 2025 at 10:00 am (ET). Results will be released that morning before 7:00 am (ET) and will be available on our website at https://bn.brookfield.com/news-events/press-releases. Participants can join by conference call or webcast: Conference CallPlease pre-register by conference call:https://register.vevent.com/register/BIf7f2f2b5bdd84f708b0fc3cd0fd714dd Upon registering, you will be emailed a dial-in number and unique PIN. This process will bypass the operator and avoid the queue.WebcastPlease join and register by webcast: https://edge.media-server.com/mmc/p/5vbgiehc/ Replay of the event is available on the above webcast link for 90 days.About...

LONDON, Jan. 13, 2025 (GLOBE NEWSWIRE) — Rezolve Ai (NASDAQ: RZLV) founder and CEO Daniel Wagner today commended the UK government’s recent decision to create a National Data Library to help give developers access to high quality data as part of a plan to fuel AI progress and high-quality AI applications, calling it a transformative step for AI innovation. However, Wagner cautioned that this invaluable dataset must remain exclusively accessible to UK-based AI companies, emphasizing its potential as a strategic national asset in the global AI race. “The National Data Library dataset would be an enormously valuable set of assets with the potential to revolutionize AI in multiple sectors,” said Wagner. “However, allowing access to this data by companies outside the UK would be a profound mistake, undermining our ability to retain...

GLENVIEW, Ill., Jan. 13, 2025 (GLOBE NEWSWIRE) — Illinois Tool Works Inc. (NYSE: ITW) will issue its fourth quarter and full year 2024 results on Wednesday, February 5, 2025 at 7:00 a.m. CST. Following the release, ITW will hold its fourth quarter and full year 2024 earnings webcast at 9:00 a.m. CST. To access the webcast for the event, please click on the following link:ITW Q4 2024 Earnings Webcast If you are a participant on the conference call, please dial 1-888-660-6652 (domestic) or 1-646-960-0554 (international) 10 minutes prior to the 9:00 a.m. CST start time. The passcode is “ITW.” Following the webcast, presentation materials and an audio webcast replay will be available at http://investor.itw.com. An audio-only replay will be available from February 5 through February 12 by dialing 1-800-770-2030 (domestic) or 1-609-800-9909...

DRAPER, Utah, Jan. 13, 2025 (GLOBE NEWSWIRE) — HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), the nation’s largest health savings account (“HSA”) custodian, today announced estimates of HSAs, HSA Assets and Total Accounts for its fiscal year ending January 31, 2025, reflecting a strong sales year with record New HSAs from Sales and strong custodial HSA Asset growth.Estimated HSAs to be approximately 9.8 million by January 31, 2025, up from 8.7 million a year earlier. Estimated HSA Assets to be approximately $31 billion, up from $25.2 billion at the end of fiscal year 2024, with approximately $17 billion of HSA Cash. Invested balances included in the estimated assets are subject to market fluctuation. Estimated Total Accounts to be approximately 17 million compared to 15.7 million at the end of fiscal...

Reports $709 million in preliminary1 full-year 2024 U.S. net product revenues$611 million in SYFOVRE® U.S. net product revenues, including $167 million in 4Q 2024 $98 million in EMPAVELI® U.S. net product revenues, including $23 million in 4Q 2024Expects submission of EMPAVELI sNDA for C3G and primary IC-MPGN in early 2025; U.S. launch anticipated in 2H 2025, if approved Plans initiation of Phase 3 studies of pegcetacoplan in two additional nephrology indications in 2H 2025 Adam Townsend, chief operating officer, to depart Apellis in February; David Acheson named executive vice president of commercial Maintained strong financial position with year-end cash of approximately $410 million; projected revenues and cash expected to be sufficient to fund operations to profitabilityWALTHAM, Mass., Jan. 13, 2025 (GLOBE NEWSWIRE) —...

Achieved in vivo preclinical proof of concept of editing hematopoietic stem cells in non-human primates as a key step toward developing a novel in vivo treatment for sickle cell disease and beta thalassemiaAchieved in vivo editing of liver cells in non-human primates and in vivo delivery to two additional cell types in humanized miceAnticipated 2025 milestones include: declare two in vivo development candidates, one in HSCs and one in liver; present further in vivo HSC data; present in vivo data in one liver indication; establish one additional target cell type/tissue; and continue to derive revenue through sublicensing foundational IPStrategic priorities through 2027 include: submit at least one IND/CTA; achieve human in vivo proof of concept in HSC editing for the treatment of sickle cell disease and beta thalassemia; and commence...

ROUYN-NORANDA, Quebec, Jan. 13, 2025 (GLOBE NEWSWIRE) — GLOBEX MINING ENTERPRISES INC. (GMX – Toronto Stock Exchange, G1MN – Frankfurt, Stuttgart, Berlin, Munich, Tradegate, Lang & Schwarz, LS Exchange, TTMzero, Düsseldorf and Quotrix Düsseldorf Stock Exchanges and GLBXF – OTCQX International in the US) is pleased to report that Brunswick Exploration Inc. (TSX-V:BRW, OTCQB:BRWXF; FRANKFURT:1XQ) have announced additional lithium bearing intersections from their 12,000 metre drill program on the Mirage Property (Lac Escale portion) in the Eeyou Istchee-James Bay area of Quebec, on which Globex retains a 3% Gross Metal Royalty. Drilling focused on the Central Zone including the MR-6 and MR-3 dykes and has continued to intersect wide and well-mineralized intervals on their extensions and to depth. Highlights include:37 meters...

The first selective Fatty Acid Binding Protein 5 inhibitor safely administered to human subjects Initial safety and pharmacokinetic data expected during the first half 2025 SOLANA BEACH, Calif., Jan. 13, 2025 (GLOBE NEWSWIRE) — Artelo Biosciences, Inc (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, or dermatologic and neurological conditions, today announced the completed safety review of the first cohort of eight healthy volunteers in the Company’s Phase 1 study of ART26.12. Progression to the next cohort marks a major milestone in the development of Fatty Acid Binding Protein (FABP) inhibitors as a novel treatment approach for a large number of potential indications. ART26.12 is the lead compound in Artelo’s proprietary...

HOUSTON, Jan. 13, 2025 (GLOBE NEWSWIRE) — Freight Technologies, Inc. (Nasdaq: FRGT, “Fr8Tech” or the “Company”), a logistics management innovation company, offering a diverse portfolio of technology-driven solutions that address distinct challenges within the supply chain ecosystem, announced today the renewal of its logistics services contract with Kimberly-Clark de México, S.A.B. de C.V. The renewed agreement extends the relationship for an additional two years and encompasses the transportation of products and goods throughout Mexico. This renewal marks the continuation of a successful collaboration that began in 2022. Since inception, the relationship between Fr8Tech and Kimberly-Clark de México has grown steadily, with significant year-over-year increases in over-the-road (OTR) load capacity and expanded service. Currently,...

Company closes 2024 with multiple award recognitions for corporate social responsibility, workplace culture, inclusion and belonging, and more BURLINGTON, Mass., Jan. 13, 2025 (GLOBE NEWSWIRE) — Progress (Nasdaq: PRGS), the trusted provider of AI-powered digital experiences and infrastructure software, today announced it has received multiple awards from prestigious organizations for its inclusive workplace, culture and focus on corporate social responsibility (CSR). Progress strives to create an environment where employees can grow to their full potential while bringing their best selves to work. The company has been acknowledged year-over-year for its people-centric approach and programs that include talent, career & leadership development, excellent benefits, its multiple employee resource groups (ERGs), and well-being...